GS-441524 (FIP) Oral Suspension (Anhydrous)
GS-441524 (FIP) is a compounded formulation containing GS-441524, prepared by Mixlab for veterinary use. Available by prescription.
How to Give Anhydrous Oral Suspension
Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:
- Shake well each time to mix the medication (5-10 seconds).
- Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
- Hold your pet steady: a towel or helper can assist with squirmy pets.
- Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
- Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
- Praise your pet and offer a treat or water (unless advised against feeding right after).
- Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
- Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.
This compounded formulation contains gs-441524, an investigational antiviral. In compounding practice, clinicians may consider it based on the established properties of the active ingredient. Your veterinarian determines whether it is appropriate for your animal.
This description reflects the general pharmacology of the active ingredient's drug class; your veterinarian determines whether this approach is appropriate for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, it acts as a competitor for viral RNA-dependent RNA polymerase, managing the replication of the FIP virus. Commonly observed effects include localized changes at the injection site or temporary digestive shifts. Because the management of FIP is a complex clinical process, your veterinarian will monitor for observational signs of recovery through regular physical exams and blood work. Owners should monitor their cat for any unusual behavioral shifts or changes in energy and contact their veterinarian promptly with concerns.
Yes. GS-441524 is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all legal authorizations before preparing any medication.
Yes. Mixlab specializes in compounding GS-441524 into customized oral formats, such as flavored capsules or liquids, to suit the specific needs of your cat. The decision rests with your prescribing veterinarian.
Veterinarians discuss GS-441524 for its ability to manage the replication of the virus that causes FIP. Its mechanism provides a method for addressing both the "wet" and "dry" forms of this feline challenge.
FIP protocols are typically characterized by a specific long-term duration. Your veterinarian will provide guidance on the expected timeline and the necessary monitoring schedule for your cat.
Your veterinarian will recommend frequent check-ups and blood tests to monitor liver and kidney values as well as markers of inflammation. This monitoring ensures the management approach remains safe.
